Prenetics Global Limited (PRENW)
USD 0.01
(19.0%)
USD 0.01
(19.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 21.74 Million USD | -92.12% |
| 2022 | 275.76 Million USD | -0.03% |
| 2021 | 275.85 Million USD | 323.22% |
| 2020 | 65.17 Million USD | 605.93% |
| 2019 | 9.23 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 6.41 Million USD | 18.14% |
| 2024 Q2 | 5.94 Million USD | -7.36% |
| 2023 Q1 | 17.7 Million USD | -66.17% |
| 2023 FY | 21.74 Million USD | -92.12% |
| 2023 Q3 | 4.86 Million USD | -14.57% |
| 2023 Q2 | 5.69 Million USD | -67.82% |
| 2023 Q4 | 5.42 Million USD | 11.57% |
| 2022 Q2 | 51.71 Million USD | -43.81% |
| 2022 Q1 | 92.04 Million USD | 42.23% |
| 2022 Q4 | 52.32 Million USD | -34.34% |
| 2022 FY | 275.76 Million USD | -0.03% |
| 2022 Q3 | 79.68 Million USD | 54.07% |
| 2021 Q2 | 79.02 Million USD | 37.54% |
| 2021 FY | 275.85 Million USD | 323.22% |
| 2021 Q1 | 57.45 Million USD | 110.66% |
| 2021 Q4 | 64.71 Million USD | -13.32% |
| 2021 Q3 | 74.65 Million USD | -5.52% |
| 2020 Q2 | 7.91 Million USD | 95.02% |
| 2020 Q1 | 4.06 Million USD | 0.0% |
| 2020 FY | 65.17 Million USD | 605.93% |
| 2020 Q4 | 27.27 Million USD | 5.2% |
| 2020 Q3 | 25.92 Million USD | 227.35% |
| 2019 FY | 9.23 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Bionano Genomics, Inc. | 36.11 Million USD | 39.798% |
| Star Equity Holdings, Inc. | 45.78 Million USD | 52.511% |
| CareDx, Inc | 280.32 Million USD | 92.244% |
| Exact Sciences Corporation | 2.49 Billion USD | 99.13% |
| Exagen Inc. | 52.54 Million USD | 58.623% |
| Inotiv, Inc. | 572.42 Million USD | 96.202% |
| Guardant Health, Inc. | 563.94 Million USD | 96.145% |
| Biodesix, Inc. | 49.08 Million USD | 55.706% |
| BioNexus Gene Lab Corp. | 9.77 Million USD | -122.527% |
| Precipio, Inc. | 15.19 Million USD | -43.072% |
| iSpecimen Inc. | 9.92 Million USD | -119.0% |
| Natera, Inc. | 1.08 Billion USD | 97.992% |
| Aspira Women's Health Inc. | 9.15 Million USD | -137.521% |
| Standard BioTools Inc. | 106.34 Million USD | 79.554% |
| 23andMe Holding Co. | 219.63 Million USD | 90.101% |
| Castle Biosciences, Inc. | 219.78 Million USD | 90.107% |
| Personalis, Inc. | 73.48 Million USD | 70.41% |
| Aclaris Therapeutics, Inc. | 31.24 Million USD | 30.421% |
| Applied DNA Sciences, Inc. | 13.36 Million USD | -62.654% |
| OpGen, Inc. | 3.41 Million USD | -536.063% |
| T2 Biosystems, Inc. | 7.19 Million USD | -202.275% |
| Myriad Genetics, Inc. | 678.4 Million USD | 96.795% |
| ICON Public Limited Company | 8.12 Billion USD | 99.732% |
| NeoGenomics, Inc. | 591.64 Million USD | 96.325% |
| Star Equity Holdings, Inc. | 45.78 Million USD | 52.511% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | 99.406% |
| RadNet, Inc. | 1.61 Billion USD | 98.655% |
| MDxHealth SA | 70.19 Million USD | 69.024% |
| Psychemedics Corporation | 22.09 Million USD | 1.608% |
| Illumina, Inc. | 4.5 Billion USD | 99.517% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 312.97 Million USD | 93.053% |
| DarioHealth Corp. | 20.35 Million USD | -6.833% |
| Fulgent Genetics, Inc. | 289.21 Million USD | 92.482% |
| Sera Prognostics, Inc. | 306 Thousand USD | -7005.449% |
| ENDRA Life Sciences Inc. | - USD | -Infinity% |
| OPKO Health, Inc. | 863.49 Million USD | 97.482% |
| Medpace Holdings, Inc. | 1.88 Billion USD | 98.847% |
| Neogen Corporation | 924.22 Million USD | 97.647% |
| Intelligent Bio Solutions Inc. | 3.11 Million USD | -598.721% |
| Prenetics Global Limited | 21.74 Million USD | 0.0% |
| Mainz Biomed B.V. | 895.47 Thousand USD | -2328.05% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -758.546% |
| Trinity Biotech plc | 56.83 Million USD | 61.742% |
| Neuronetics, Inc. | 71.34 Million USD | 69.526% |
| Sotera Health Company | 1.04 Billion USD | 97.928% |
| bioAffinity Technologies, Inc. | 2.53 Million USD | -758.546% |